InvestorsHub Logo
Followers 2
Posts 59
Boards Moderated 0
Alias Born 01/04/2018

Re: None

Monday, 12/31/2018 10:15:05 AM

Monday, December 31, 2018 10:15:05 AM

Post# of 894
Relationship b/w AHG and MedMen?

News Release:

Alternate Health Signs Agreement with Medmen to Launch Statepass Beta in New York Dispensaries

https://www.prnewswire.com/news-releases/alternate-health-signs-agreement-with-medmen-to-launch-statepass-beta-in-new-york-dispensaries-675529303.html

("Alternate Health" or the "Company") (CSE:AHG) (OTCQB:AHGIF), an international corporation that provides software solutions for the medical cannabis industry, today announced that the Company has entered into a software-as-a-service agreement with MedMen, one of the largest cannabis companies in the U.S., to provide e-commerce and digital payment services. Alternate Health's StatePass system will begin beta testing with MedMen in their New York dispensaries.

"We are very pleased to be working with MedMen as Alternate Health expands into another key state in the U.S. market," said Dr. Michael Murphy, Chairman and CEO of Alternate Health. "The implementation of CanaPass in Canada as well as beta testing in Florida have seen overwhelmingly positive response from our customers and we look forward to serving the medical cannabis community in New York with our state-of-the-art system."

The StatePass system is a cloud-based software platform that manages the end-to-end transactions involved in providing safe access to medical cannabis to eligible patients. The database is accessible by the patient, certified doctors and licensed dispensaries, linked through a seamless interface, and is used to monitor the individual patient and provide enhanced treatment recommendations, with a focus on improving patient outcomes.

"Alternate Health's agreement with MedMen is perfectly aligned with our goal of bringing best-in-class software solutions to the medical cannabis market," said Jay Briggs, Vice President of Operations of Alternate Health. "This is an exciting opportunity to work side-by-side with another leading company in the cannabis industry and open up new revenue streams in New York's tremendously promising market."